Key result
SAMe-TT2R2 score-guided education fails to provide cost-effective benefit over usual care.
Why the study?
Atrial fibrillation imposes substantial costs in Thailand with patients often relying on warfarin with suboptimal anticoagulation control, motivating evaluation of a score-guided educational intervention.
Does a SAMe-TT2R2 score-guided educational intervention improve cost-effectiveness and anticoagulation control in anticoagulant-naïve Thai patients with atrial fibrillation?
RCT
Yes
Does a SAMe-TT2R2 score-guided educational intervention improve cost-effectiveness and anticoagulation control in anticoagulant-naïve Thai patients with atrial fibrillation?
Mean Difference: -0.03
A SAMe-TT2R2 score-guided educational intervention is not cost-effective for improving anticoagulation control or quality of life in Thai patients with atrial fibrillation compared to usual care.
No TTR benefit from score-guided education in Thai AF; leaves open whether targeted interventions improve warfarin control in resource-limited settings.
Background Atrial fibrillation imposes substantial costs with Thai patients often relying on warfarin with suboptimal control. Objective To establish cost-effectiveness for the Thai health system of a SAMe-TT 2 R 2 score-guided treatment strategy with educational intervention to improve patients' anticoagulation control with warfarin. Methods A trial-based economic evaluation compared the score-guided treatment strategy with educational intervention against usual care in Thai Primary Care and Pharmacies. A trial-based cost-utility analysis estimated the cost-per-additional QALY of the strategy, whilst a cost-effectiveness analysis established cost-per-percentage point increase in time in therapeutic range (TTR) Results The intervention had higher costs and lower QALYs than usual care, with an incremental cost of Thai baht (THB) 3,359 and incremental QALY difference of −0.03. Consistent with this finding, the bootstrapped analysis showed the intervention had a low probability of being cost-effective: 4% at a willingness-to-pay threshold of THB 160,000 per QALY. Results were robust to sensitivity analyses. Despite lower quality of life outcomes, the cost-effectiveness analysis suggested a small uncertain improvement in TTR with 62% of bootstrapped replications favouring the intervention and mean increase of 0.92 percentage points, for an additional cost of around THB 3500. Higher costs were driven mainly by intervention costs. Conclusion It is highly likely a SAMe-TT 2 R 2 score-guided strategy with educational intervention alongside usual care (TREATS-AF) is not cost-effective in terms of cost-per-additional QALY or improved anticoagulation control (TTR), in anticoagulant-naïve Thai patients with AF, when compared with usual care alone. This suggests that this type of intervention may require further local adaptation and context-specific evaluation.
No takes yet. Share an insight, caveat, or question.
Hall et al. (2026) conducted an RCT in Atrial fibrillation. SAMe-TT2R2 score-guided treatment strategy with educational intervention vs. Usual care was evaluated on Cost-per-additional QALY (incremental QALY difference -0.03). A SAMe-TT2R2 score-guided educational intervention was not cost-effective compared to usual care, resulting in an incremental cost of THB 3,359 and an incremental QALY difference of -0.03.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: